Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Shingo, Hachinohe"'
Autor:
Tohru Yoneyama, Shingo Hatakeyama, Mihoko Sutoh-Yoneyama, Taku Yoshiya, Tsuyoshi Uemura, Takehiro Ishizu, Minoru Suzuki, Shingo Hachinohe, Shintaro Ishiyama, Motohiro Nonaka, Michiko N. Fukuda, Chikara Ohyama
Publikováno v:
BMC Cancer, Vol 21, Iss 1, Pp 1-15 (2021)
Abstract Background p-Boronophenylalanine (10BPA) is a powerful 10B drug used in current clinical trials of BNCT. For BNCT to be successful, a high (500 mg/kg) dose of 10BPA must be administered over a few hours. Here, we report BNCT efficacy after r
Externí odkaz:
https://doaj.org/article/a8a6401007f9447bab9c5194fe2dff25
Autor:
Tohru Yoneyama, Shingo Hatakeyama, Mihoko Sutoh Yoneyama, Taku Yoshiya, Tsuyoshi Uemura, Takehiro Ishizu, Minoru Suzuki, Shingo Hachinohe, Shintaro Ishiyama, Motohiro Nonaka, Michiko N. Fukuda, Chikara Ohyama
Publikováno v:
BMC Cancer, Vol 21, Iss 1, Pp 1-5 (2021)
An amendment to this paper has been published and can be accessed via the original article.
Externí odkaz:
https://doaj.org/article/a1d6f3d092594bd5b59f80670477a420
Autor:
Ishiyama Shintaro, Michiko N. Fukuda, Mihoko Sutoh Yoneyama, Chikara Ohyama, Takehiro Ishizu, Shingo Hachinohe, Tohru Yoneyama, Motohiro Nonaka, Tsuyoshi Uemura, Minoru Suzuki, Taku Yoshiya, Shingo Hatakeyama
Publikováno v:
BMC Cancer, Vol 21, Iss 1, Pp 1-5 (2021)
An amendment to this paper has been published and can be accessed via the original article.
Autor:
Tohru Yoneyama, Shingo Hatakeyama, Mihoko Sutoh Yoneyama, Taku Yoshiya, Tsuyoshi Uemura, Takehiro Ishizu, Minoru Suzuki, Shingo Hachinohe, Shintaro Ishiyama, Motohiro Nonaka, Michiko N. Fukuda, Chikara Ohyama
Publikováno v:
Journal of Urology. 207
Autor:
Chikara Ohyama, Shingo Hachinohe, Mihoko Sutoh Yoneyama, Minoru Suzuki, Ishiyama Shintaro, Tohru Yoneyama, Shingo Hatakeyama, Michiko N. Fukuda, Tsuyoshi Uemura, Taku Yoshiya, Takehiro Ishizu, Motohiro Nonaka
Publikováno v:
BMC Cancer
BMC Cancer, Vol 21, Iss 1, Pp 1-15 (2021)
BMC Cancer, Vol 21, Iss 1, Pp 1-15 (2021)
Background p-Boronophenylalanine (10BPA) is a powerful 10B drug used in current clinical trials of BNCT. For BNCT to be successful, a high (500 mg/kg) dose of 10BPA must be administered over a few hours. Here, we report BNCT efficacy after rapid, ult
Autor:
Tohru, Yoneyama, Shingo, Hatakeyama, Mihoko, Sutoh Yoneyama, Taku, Yoshiya, Tsuyoshi, Uemura, Takehiro, Ishizu, Minoru, Suzuki, Shingo, Hachinohe, Shintaro, Ishiyama, Motohiro, Nonaka, Michiko N, Fukuda, Chikara, Ohyama
Publikováno v:
BMC Cancer
p-Boronophenylalanine ((1) IF7 conjugates of eitherIntravenous injection of IF7C conjugates of eitherWe conclude that IF7 serves as an efficient
Autor:
Yoneyama, Tohru1,2 (AUTHOR), Hatakeyama, Shingo2 (AUTHOR), Sutoh-Yoneyama, Mihoko3 (AUTHOR), Yoshiya, Taku4 (AUTHOR), Uemura, Tsuyoshi4 (AUTHOR), Ishizu, Takehiro4 (AUTHOR), Suzuki, Minoru5 (AUTHOR), Hachinohe, Shingo6 (AUTHOR), Ishiyama, Shintaro7 (AUTHOR), Nonaka, Motohiro8 (AUTHOR), Fukuda, Michiko N.9 (AUTHOR), Ohyama, Chikara2 (AUTHOR) coyama@hirosaki-u.ac.jp
Publikováno v:
BMC Cancer. 1/14/2021, Vol. 21 Issue 1, p1-15. 15p.